Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Principal Real Estate	PGZ	15. nov 2024	10.39	-0.10
Principal Shareholder Yield Index ETF	PY	15. nov 2024	50.88	-0.59
Principal U.S. Small Cap Index ETF	PSC	15. nov 2024	53.21	-1.75
Priority Income Fund	PRIF-L	15. nov 2024	23.67	+0.04
Priority Income Fund	PRIF-K	15. nov 2024	22.28	-2.07
Priority Income Fund D Pref	PRIF-D	15. nov 2024	24.20	-0.41
Priority Income Fund F Pref	PRIF-F	15. nov 2024	24.17	0.00
Priority Income Fund G Pref	PRIF-G	15. nov 2024	24.31	-0.53
Priority Income Fund I Pref	PRIF-I	15. nov 2024	23.90	0.00
Priority Income Fund J Pref	PRIF-J	15. nov 2024	23.51	+0.93
Priority Income Fund Pref	PRIF-H	15. nov 2024	24.08	-0.86
Priority Technology	PRTH	15. nov 2024	7.99	-2.80
Privia Health Group	PRVA	15. nov 2024	21.20	-2.26
Pro-Dex	PDEX	15. nov 2024	46.11	-3.56
ProAssurance	PRA	15. nov 2024	16.88	+0.42
Procaps Group	PROC	15. nov 2024	0.69	-13.21
Procept BioRobotics	PRCT	15. nov 2024	88.94	+3.53
Processa Pharmaceuticals	PCSA	15. nov 2024	1.01	-4.23
Procore Technologies	PCOR	15. nov 2024	69.15	-3.44
Procter & Gamble	PG	15. nov 2024	169.54	+1.47
Professional Diversity Network	IPDN	15. nov 2024	0.95	+5.58
Proficient Auto Logistics	PAL	15. nov 2024	9.54	+4.26
Profire Energy	PFIE	15. nov 2024	2.52	-0.20
Profound Medical	PROF	15. nov 2024	8.01	-0.02
ProFrac A	ACDC	15. nov 2024	6.43	-4.17
PROG	PRG	15. nov 2024	47.72	-0.15
Progress Software	PRGS	15. nov 2024	66.51	-1.10
Progressive	PGR	15. nov 2024	255.78	-0.67
Progyny	PGNY	15. nov 2024	13.77	-1.50
ProKidney	PROK	15. nov 2024	1.70	-21.16

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.